Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001650664-25-000009
Filing Date
2025-02-28
Accepted
2025-02-28 16:40:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3518
  Complete submission text file 0001650664-25-000009.txt   4900
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Subject) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37687 | Film No.: 25691176
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
O'Neill Gilmore Neil (Reporting) CIK: 0001742084 (see all company filings)

Type: 144